Journal of the American Heart Association
Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events: A Cohort Study
Study in peopleInterventions
The paper
Amgen (United States); Yale University
Journal of the American Heart Association, 18 Sep 2026

